Term Sheet Negotiation for Startups in India: Founders & Indian VCs

Most founders who lose control of their companies, or walk away from exits with far less than expected, do not point to a single dramatic clause. They trace the problem back to a term sheet they did not push back on hard enough, usually because they were told the economics looked fine. The economics did look fine. The control provisions did not.

The term sheet stage is where that gap opens. This article is about closing it before you sign.

Why the term sheet matters more than founders think

The standard framing is that a term sheet is mostly non-binding, so you can correct anything in the SHA. That framing is wrong in practice. Valuations, liquidation preference structure, ESOP pool size, board composition, and anti-dilution mechanics agreed at the term sheet stage almost never change by the time definitive documents are signed. By the time lawyers are drafting the SHA and SSA, both sides have committed reputational capital to the deal. Reopening economic terms at that point is treated as bad faith. Investors have seen that playbook before.

What you agree to in principle at the term sheet stage is what you will live with for the next five to seven years.

The mistakes below often coming in term sheet are drawn from live deal reviews across seed and Series A rounds in India, not from generic fundraising advice.

Mistake 1: Treating valuation as the only number that matters

Founders obsess over the headline pre-money valuation. The number gets announced to co-founders, shared in WhatsApp groups, and occasionally leaked to the press. It is the wrong number to optimise.

The number that determines how much you actually own after the round is the fully diluted post-money ownership percentage, calculated after accounting for three things that are usually buried in the term sheet: the ESOP pool, the instrument structure (CCPS or CCD), and the conversion ratio.

The ESOP pool shuffle

Indian VCs almost universally ask for the ESOP pool to be created or topped up before the investment is priced. This is called the pre-money pool, and it means founders bear the entire dilution cost before the investor’s ownership is even calculated.

Here is what this looks like in numbers:

Scenario	Pre-money valuation	ESOP pool (15%) timing	Founder ownership post-investment
ESOP pool pre-money	₹40 Cr	Created before investment	~55%
ESOP pool post-money	₹40 Cr	Created after investment	~62%
No ESOP top-up required	₹40 Cr	Existing pool used	~68%

Table 1: How ESOP pool timing affects founder dilution at a ₹40 Cr pre-money valuation with ₹10 Cr investment. Assumes 20% investor stake.

A 7-percentage-point difference in founder ownership on a company that exits at ₹500 Cr is approximately ₹35 crores. That is the cost of not negotiating the pool timing.

The correct ask is: ESOP pool to be created post-money, sized to cover a realistic 18-24 month hiring plan with a 20% buffer. Investors will push back. Your leverage depends entirely on whether you have competing term sheets or strong deal metrics. If you do, use it here.

Mistake 2: Not understanding what CCPS means in a down round

Nearly every foreign VC investment in India is structured as Compulsorily Convertible Preference Shares (CCPS), and rightly so: FEMA treats CCPS as equity capital instruments under the NDI Rules, which is mandatory for the automatic FDI route. Domestic funds may use CCDs (Compulsorily Convertible Debentures) instead, which carry different tax treatment and IBC implications.

Most founders know CCPS is standard. Very few understand what happens to CCPS in a down round, and that is where the real risk sits.

CCPS holders have a liquidation preference over ordinary equity shareholders. The two structures you will see in Indian term sheets are:

1x non-participating: Investor gets back invested capital (1x) or converts to equity at IPO/exit, whichever is higher. This is founder-friendly and the market standard for good-faith term sheets.

Participating preferred (with or without cap): Investor gets 1x back first, and then participates in the remaining proceeds as if fully converted. In a modest exit (say a ₹150 Cr acquisition on a ₹100 Cr post-money round), a participating preferred investor could take ₹100 Cr in preference plus a proportionate share of the remaining ₹50 Cr, leaving founders with very little.

The word “participating” appearing anywhere in the liquidation preference section of your term sheet warrants a hard conversation. Uncapped participation is non-standard for early-stage Indian VC deals and should be refused. A capped participation (typically 2-3x) is negotiable if the investor insists, but the right default position is 1x non-participating.

Mistake 3: Ignoring the anti-dilution clause type

Anti-dilution protection is not negotiable in principle: investors will have it. What is negotiable is the mechanism, and the difference between the two common types is severe.

Broad-based weighted average: The conversion price adjusts downward in a down round, but the adjustment accounts for the size of the down round and the total share count. This is the market standard. It is fair to both sides.

Full ratchet: The conversion price resets to the new (lower) round price, regardless of round size. If you raised at ₹100 per share and your next round comes in at ₹60, the full ratchet investor’s entire holding reprices to ₹60. The dilution to founders can be catastrophic.

Full ratchet anti-dilution in an Indian term sheet is a red flag about the investor’s negotiating posture, not just about that specific clause. Any fund inserting full ratchet at seed or Series A is applying PE-era terms to VC-era risk. Push back explicitly, offer weighted average broad-based as the mutual standard, and document the investor’s response. If they hold firm, factor it into your read of the relationship.

Mistake 4: Accepting protective provisions without scoping them, and not knowing how much they have expanded

Protective provisions (also called reserved matters or consent rights) give investors a veto over specific company decisions. In the term sheet, they are usually listed broadly as something like “standard protective provisions.” That phrase does a lot of work, and since 2022, it has been doing considerably more work than it used to.

A series of well-documented governance failures at prominent Indian startups between 2021 and 2023 changed the Indian VC market’s posture on protective provisions permanently. Investors who were previously comfortable with light information rights and observer seats now routinely negotiate clauses that would have been considered aggressive at Series B just four years ago. If you are raising in 2025, you are negotiating in that environment whether you know it or not.

What the new generation of Indian VC protective provisions looks like:

By the time the SHA is drafted, provisions flagged as “standard” in the term sheet can include:

• Approval for any new hire above a salary threshold (sometimes as low as ₹50 lakhs per annum)
• Veto on any ESOP grant above a specified size
• Consent required for any related-party transaction (including founder salary increases)
• Approval for office leases above a certain monthly rent
• Veto on the company entering any new business line
• Investor approval required for appointment of the CFO and other key managerial personnel
• Mandatory formation of an audit committee and compensation committee with investor-nominated members
• Expanded “bad leaver” definitions, previously limited to fraud or wilful misconduct, now regularly including any criminal complaint against the founder, breach of non-compete provisions, and breach of any investment document (not just the SHA)
• Covenants requiring founder disclosure of income from other companies and explicit conflict-of-interest representations
• Periodic compliance checks as a condition for continued investment

None of these clauses are unreasonable in the abstract: investors watched real money disappear because they had insufficient oversight. But the expansion of “bad leaver” definitions deserves specific attention from every founder. The old bad leaver standard was narrow: the investor could force a founder out at a penalty valuation if there was proven fraud. The new standard in many Indian term sheets can trigger the same outcome on a criminal complaint (not conviction), or a technical breach of a representation in the investment documents.

A complaint from a disgruntled employee or a competitor can now, under poorly scoped bad leaver provisions, give an investor the contractual right to treat a founder as a bad leaver. That is a material shift in risk for founders, and it is happening at the term sheet stage, not in the SHA.

The fix has two parts. First, define exactly which categories of decisions require investor consent, tie each category to a clear threshold, and carve out ordinary course operations explicitly. Second, negotiate the bad leaver definition specifically: the trigger should be a final court order or equivalent regulatory finding, not a complaint or allegation.

A related Treelife article on founder vesting and SHA provisions covers how these provisions interact with founder lock-in mechanics.

Mistake 5: Not distinguishing board composition from board control

An investor asking for one board seat on a five-member board sounds reasonable. But term sheets often do not specify the full board composition: they specify only the investor seat. The mechanism for how other seats are filled, and how the independent director is selected, can determine who actually controls the company.

The model that preserves operational control for founders is:

• Two founder-nominated directors
• One investor-nominated director
• One independent director (selected jointly, with founder approval right)
• Quorum requirements that cannot be met without founder-nominated directors present

The model that silently shifts control to investors is:

• One founder director
• One investor director
• One independent director nominated by the investor
• Quorum not requiring both founder directors

Both structures can appear on the surface to be “balanced 3-member boards.” The devil is in the quorum and nomination mechanics, which belong in the term sheet, not left to be resolved in the SHA.

Treelife note: In more than half the contested board-composition situations we have seen in Indian Series A rounds, the problem traced back to a term sheet that said “one investor board seat” without specifying the full composition framework. If the term sheet does not answer who nominates the independent director and what the quorum looks like, you are leaving a material question unresolved.

Mistake 6: Accepting drag-along terms without a price floor or threshold

Drag-along rights allow majority shareholders to compel minority shareholders to sell in the event of an acquisition. In principle, this is reasonable: you do not want one small investor blocking a clean exit. In practice, drag-along clauses in Indian term sheets from PE-style domestic funds are often drafted to allow drag at any price, triggered by a simple majority of all shareholders (not just investors).

This creates a scenario where your investors can sell the company at a price that gives you nothing after their liquidation preference is satisfied, and they can drag you along into that sale.

The negotiation points that matter on drag-along:

• Minimum price floor before drag can be triggered (typically 1x or 1.5x the post-money valuation of the current round, at minimum)
• Minimum return threshold for founders before drag is exercisable
• Supermajority threshold (typically 75% of all shareholders, not just preferred holders) required to trigger drag
• Founder consent required if the exit price falls below a specified IRR for founders

Not all of these will be accepted by every investor. But asking for a price floor is entirely standard: drag-along without any floor is an aggressive term that no founder should accept without significant pushback.

Mistake 7: Treating the no-shop period as a formality

The no-shop (or exclusivity) clause in a term sheet prevents founders from approaching other investors for a specified period after signing. It exists to protect the lead investor’s diligence process, which is legitimate. What is not legitimate is an indefinitely open or excessively long no-shop window.

The Indian market standard is 30 to 45 days. Sixty days is at the outer edge of acceptable. Anything beyond 60 days should require a specific explanation from the investor. An 8-to-12-week no-shop with no clear timeline commitment from the investor on closing is a term that functionally locks you out of competing capital for a quarter.

Founders sign long no-shop periods for one reason: they are afraid that asking to shorten it will signal lack of conviction in the investor. That reasoning inverts the dynamic. A serious investor who intends to close within 45 days has no need for a 90-day exclusivity window. The length of the no-shop is data about the investor’s intent.

The ask is simple: tie the no-shop duration to a binding timeline commitment from the investor. If they will close within 45 days, the no-shop is 45 days. If they need 60 days, define the milestones that determine whether closing happens at day 60 or not.

Mistake 8: Agreeing to tranched investment without defining the milestones

Tranched investment (where the investor commits a total amount but releases it in stages tied to milestones) has become more common in Indian VC deals since 2022. For investors, it reduces risk: they get to see execution before committing the full cheque. For founders who do not read the tranche structure carefully, it can convert a closed round into an open-ended negotiation.

The problem is not tranching itself. The problem is milestone definitions that sit somewhere between vague and entirely at the investor’s discretion.

Here is what a bad tranche structure looks like in practice:

• Tranche 1: ₹3 Cr on signing
• Tranche 2: ₹3 Cr on “achievement of growth milestones satisfactory to the investor”
• Tranche 3: ₹4 Cr on “board approval at the time of disbursement”

That phrasing gives the investor unilateral discretion to withhold Tranche 2 and 3 indefinitely. You have announced a ₹10 Cr round. You have ₹3 Cr in the bank. Your hiring plan, product roadmap, and Series A timeline were all built on ₹10 Cr. And the investor can legally claim the milestones were not met to their satisfaction.

Some investors use KPI-linked tranches as a governance mechanism: they want to see quarterly financial targets, specific user numbers, or regulatory approvals before releasing subsequent capital. That is defensible in principle. What is not defensible is milestone language that leaves measurement entirely to the investor.

The correct structure has three components. First, milestones must be specific and objectively measurable: a number, a date, or a binary event (regulatory approval received / not received). Phrases like “satisfactory to the investor” or “as reasonably determined by the board” belong in a consulting contract, not a term sheet. Second, the timeline for each tranche must be specified, not just the milestone but the outside date by which the tranche must be disbursed if the milestone is met. Third, there should be a clear dispute resolution mechanism if the investor and founder disagree on whether a milestone has been achieved.

If an investor insists on milestone-linked tranches without clear definitions, ask for a deemed achievement clause: if the investor does not provide a written objection with specific reasons within 15 business days of a milestone notice from the company, the milestone is treated as met.

The related risk: some Indian term sheets now include an automatic exclusivity renewal provision if the deal does not close by the original longstop date due to delays caused by the company. Combined with an undefined tranche structure, this means a founder can be locked into a single investor, unable to close the round, and unable to approach other investors, all because a milestone was not achieved to someone’s unstated standard.

A quick reference: Indian VC term sheet benchmarks

Table 2: Market standards for key term sheet clauses in Indian seed and Series A rounds (2024-25)

Clause	Market standard (founder-friendly)	Watch for
ESOP pool timing	Post-money	Pre-money pool as a condition of term sheet
ESOP pool size	10-15% for seed; 12-18% for Series A	Pools above 18% pre-money without hiring plan
Liquidation preference	1x non-participating CCPS	Participating preferred, especially uncapped
Anti-dilution	Broad-based weighted average	Full ratchet: walk away
Board composition	2 founder seats, 1 investor seat, 1 joint independent	Investor-nominated independent director
Drag-along trigger	75%+ of all shareholders, with price floor	Simple majority drag with no price floor
No-shop period	30-45 days	Anything above 60 days without close timeline
Founder vesting post-investment	3-4 years with 1-year cliff, credit for time served	Fresh 4-year vesting with no credit
Protective provisions	Limited to major corporate actions	CFO appointment rights, low salary thresholds, operational vetos
Bad leaver definition	Limited to proven fraud or wilful misconduct	Criminal complaint (not conviction) as trigger; any document breach
Tranched investment	Objectively measurable milestones with outside disbursement dates	“Satisfactory to investor” language; no outside date
Exclusivity renewal	Not automatic; requires mutual agreement	Auto-renewal on company-caused delays

Case study: The ESOP pool shuffle that cost a founder 8%

Situation: Seed-stage fintech founder, Bengaluru, raising ₹6 Cr at a ₹34 Cr pre-money valuation from a domestic angel syndicate.

Challenge: Term sheet specified a 15% ESOP pool to be created pre-money as a condition of closing. Founders had not modelled the dilution impact separately. The investor framed it as standard. Founders were also under a 45-day no-shop with no competing term sheet.

What Treelife did: Ran a full cap table model showing that the pre-money pool dropped founder effective pre-money to approximately ₹28.9 Cr (the ESOP pool representing ₹5.1 Cr of value absorbed before the investor priced in). Proposed shifting 8% of the pool post-money with only 7% pre-money, tied to a specific 18-month hiring plan signed off by the syndicate. Also renegotiated the no-shop from 45 to 30 days with a clear DD timeline.

Outcome: Founders retained approximately 6.3% more equity post-close. At a conservative 5x exit multiple on ₹34 Cr pre-money, that 6.3% translated to approximately ₹10.7 crores of additional founder proceeds. The syndicate agreed: they had no material objection once the hiring plan was tabled as justification.

FAQ on Term Sheet Negotiation for VCs – Indian Starups

Q: Is a term sheet legally binding in India?
A: No, a term sheet is mostly non-binding. However, specific clauses (confidentiality, exclusivity/no-shop, and sometimes cost provisions) are expressly binding. Courts in India have also found that where parties acted substantively on a term sheet’s provisions (as in the Zostel vs. OYO litigation), there can be arguments for enforceability even of nominally non-binding provisions. Do not treat “non-binding” as a reason to be less careful.

Q: What is the standard liquidation preference in Indian VC deals?
A: 1x non-participating is the market standard for seed and Series A in India. This means investors recover their invested capital first in a liquidation or exit, and then convert into ordinary equity for the remaining proceeds. Participating preferred (where investors take their 1x back and then participate pro-rata) is a harder term that founders should push back on.

Q: Can I negotiate the ESOP pool size in a term sheet?
A: Yes. You can negotiate both the size and the timing. Prepare a detailed 18-24 month hiring plan that supports a specific pool percentage. Investors typically ask for 15-20%; the defensible range based on an actual hiring plan is often 10-15% for seed and early Series A. The bigger lever is timing: moving the pool to post-money is worth more to you than a 2% reduction in pool size.

Q: What is the difference between CCPS and CCD for Indian startup funding?
A: Both are FDI-compliant equity instruments under FEMA. CCPS are preference shares that mandatorily convert into equity at a trigger event such as an IPO, acquisition, or a longstop conversion date specified in the term sheet (the Companies Act 2013 requires that preference shares not remain unredeemed/unconverted for more than 20 years under Section 55, though conversion trigger dates in startup deals are typically set at 7 to 10 years). CCDs are debentures that also mandatorily convert into equity, with a maximum 10-year tenure under RBI guidelines. The key difference is tax treatment: interest on CCDs is tax-deductible for the company under Section 36(1)(iii) of the IT Act (making them useful for cash-flow management); dividends on CCPS are not deductible. Post the Supreme Court’s November 2023 ruling, CCD holders are treated as financial creditors under IBC until conversion, a meaningful distinction in distress scenarios.

Q: What anti-dilution protection should I accept?
A: Broad-based weighted average anti-dilution is the standard and is acceptable. It adjusts the investor’s conversion price proportionally in a down round, sharing the economic pain between founders and investors. Full ratchet anti-dilution (which reprices the investor’s entire holding to the new lower round price) is rarely justified at seed or Series A and is a significant red flag. If an investor insists on full ratchet, that is your data point about how they will behave when the business hits a rough patch.

Q: How long is a standard no-shop period in India?
A: 30 to 45 days is standard. 60 days is at the outer limit. Anything beyond 60 days warrants a direct conversation about the investor’s closing timeline and their readiness to commit.

Q: What are protective provisions and why do they matter?
A: Protective provisions (reserved matters) are decisions that require investor consent even though the investor holds a minority stake. They are standard in Indian VCs deals: investors get a say on major corporate actions like issuing new shares, changing the articles, or selling the company. What matters is the scope. Operational decisions (hiring, salary increases, lease renewals) should not require investor consent. If the term sheet says “standard protective provisions” without listing them, get a list before signing.

Q: What is double-trigger acceleration in founder vesting?
A: If you have founder vesting (as most investors will require post-investment), acceleration provisions determine what happens to unvested shares if the company is acquired. Single-trigger acceleration: all unvested shares vest on an acquisition. Double-trigger acceleration: unvested shares vest only if the founder is also terminated without cause within 12-18 months of the acquisition. Most acquirers and investors prefer double-trigger; single-trigger can complicate M&A. The key is having some acceleration provision, as many Indian term sheets are silent on this, leaving founders exposed if they are pushed out post-acquisition.

Q: Can angel tax affect my CCPS issuance in 2025?
A: No. The Finance Act 2024 abolished angel tax (Section 56(2)(viib) of the IT Act) for all classes of investors with effect from 01/04/2025. CCPS issued at a premium over FMV no longer triggers tax at the company level. The conversion event itself remains tax-exempt under Section 47(xb) of the IT Act, which excludes conversion of preference shares into equity from the definition of “transfer.” This removes a significant friction from CCPS-based fundraising at high valuations.

Q: What happens if a VC walks away after I have signed a no-shop?
A: The no-shop clause typically provides for a cost-recovery mechanism if either party withdraws without cause. In practice, enforcing cost claims against a fund that walks away is difficult and commercially inadvisable. The better protection is a shorter no-shop window tied to clear milestone commitments: due diligence completion date, investment committee approval date, and longstop date, so that if the investor misses their own timeline, the exclusivity lapses automatically.

Q: Is a term sheet from a PE-style domestic fund different from a tech VC term sheet?
A: Yes, meaningfully. Domestic PE-oriented funds (which invest in growth-stage companies across sectors) frequently use more aggressive protective provisions, fuller participation rights, and stronger drag-along clauses than tech-focused VCs. They have more experience enforcing these terms because their portfolio companies have more varied outcomes. The market standard benchmarks described in this article are most applicable to SEBI-registered Category I and II AIFs investing in early-stage tech or D2C companies. If you are raising from a fund with a PE heritage, get a lawyer who has specifically reviewed that fund’s SHA templates before you sign the term sheet.

Q: Should I hire a lawyer just for the term sheet stage?
A: Yes. The standard objection is that the term sheet is non-binding, so legal fees at this stage are premature. That reasoning is backward. The term sheet stage is the only point at which you have genuine negotiating leverage on economic and control terms. Once the SHA drafting starts, the cost and timeline pressure of closing will make it politically difficult to revisit anything. A senior legal review at the term sheet stage, before you sign, costs a fraction of what the mistakes in a signed term sheet will cost you at exit.

Q: What does “fully diluted basis” mean and why does it matter?
A: Fully diluted basis means your ownership percentage calculated assuming all convertible instruments (CCPS, CCDs, ESOPs, warrants, convertible notes) have converted into equity. Investors always quote valuation and ownership on a fully diluted basis. Founders sometimes quote their nominal equity ownership (before conversion of all instruments). Make sure every ownership percentage in the term sheet is explicitly stated as fully diluted: if it is not, the number is meaningless for planning purposes.

Q: How should tranched investment milestones be defined in a term sheet?
A: Every milestone that triggers a tranche disbursement must be specific and objectively verifiable: a number, a date, or a binary event. Acceptable examples: “Monthly Active Users exceeding 50,000 as measured by the company’s analytics platform for two consecutive months” or “receipt of DPIIT recognition certificate.” Unacceptable: “achievement of growth milestones satisfactory to the investor” or “as determined by the board.” Alongside each milestone, negotiate an outside disbursement date: if the milestone is met by date X, the tranche must be released within 10 business days. Also negotiate a deemed achievement clause: if the investor does not raise a written objection within 15 business days of a milestone notice, the milestone is treated as met. Without these protections, a tranched term sheet can leave you operationally dependent on capital that the investor can legitimately withhold.

Q: How has the “bad leaver” definition changed in Indian VC term sheets?
A: Until 2021, the standard bad leaver trigger in Indian SHA and term sheets was narrow: proven fraud, wilful misconduct, or moral turpitude. A bad leaver event typically allowed the investor to buy back the founder’s unvested shares at nominal or below-market value. Post the governance failures at several high-profile Indian startups, investors have expanded bad leaver definitions to include: any criminal complaint filed against the founder (not requiring conviction), breach of non-compete or non-solicitation provisions, and breach of any representation or covenant in the investment documents. The last category is particularly dangerous: a minor compliance lapse or a disputed warranty can now contractually trigger bad leaver consequences. Founders should negotiate the trigger back to a final, non-appealable court order or equivalent regulatory finding, with a specific cure period (typically 30 days) for any alleged document breach before bad leaver status can be invoked.

Regulatory references:

• Companies Act 2013: Sections 42, 55, 62, 71(1) (CCPS and CCD issuance, conversion, shareholder approval requirements; Section 55 caps preference share tenure at 20 years for infrastructure companies, with a general prohibition on irredeemable preference shares)
• Foreign Exchange Management (Non-Debt Instruments) Rules, 2019: Rule 2(e) (definition of capital instruments including CCPS and CCDs under FDI)
• Income Tax Act 1961: Section 47(xb) (conversion of preference shares to equity not a transfer), Section 36(1)(iii) (interest deductibility for CCDs), Section 56(2)(viib) (angel tax, abolished for all investors from 01/04/2025 per Finance Act 2024)
• RBI guidelines on pricing of CCPS and CCDs: internationally accepted pricing methodologies, arm’s length valuation by CA or SEBI-registered merchant banker
• SEBI AIF Regulations 2012 (applicable to institutional investors who are Category I or II AIFs)
• Insolvency and Bankruptcy Code 2016: treatment of CCD holders as financial creditors (Supreme Court, November 2023)

External sources:

• sebi.gov.in
• rbi.org.in
• mca.gov.in
• incometaxindia.gov.in